Granules India has received USFDA approval to market a generic medication for major depressive disorder, Bupropion Hydrochloride extended-release tablets USP (SR), expanding its presence in the US ...
Granules Pharmaceuticals, Inc., a 100% foreign subsidiary of Granules India received the U.S. Food & Drug Administration (USFDA) approval for abbreviated new drug application (ANDA) of Bupropion ...
The first rollout of the vaccine will be in Bayelsa and Kebbi, two states with high seasonal transmission of malaria.
COUNCIL chiefs have upheld a decision to re-locate Ulverston’s library service despite a consultation being labelled ‘not fair’ ...
The global fight against cancer is intensifying, and with it, the demand for innovative treatments is soaring. One of the ...
Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...
A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...
Wave Life Sciences' alpha-1 antitrypsin deficiency candidate WVE-006 succeeded in the first-ever clinical demonstration of ...
With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...
The lawsuit focuses on scientific work that helped clear the path for creating mRNA vaccines to fight the COVID-19 pandemic.
GSK's gepotidacin, an oral antibiotic for uUTIs, could be the first in over 20 years. The FDA granted Priority Review with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback